Explore the development and validation of sensitive qPCR assays for monitoring adeno-associated virus (AAV) shedding during clinical development.

In this webinar, our scientific experts discuss the critical role of PCR-based viral shedding assays in supporting the safety assessment of AAV gene therapies. Learn how robust assay development and validation strategies enable reliable detection of viral vectors across multiple biological matrices to support regulatory expectations and clinical studies.

In this webinar, you'll learn:

• Why PCR-based viral shedding studies are essential for evaluating the safety of AAV-based therapies
• The challenges of monitoring viral shedding across diverse biological matrices, including blood, serum, urine, stool, and semen
• Best practices for developing and validating sensitive, robust qPCR assays for AAV detection
• Key considerations for supporting viral shedding assessments throughout clinical development

As gene therapies continue to advance, reliable viral shedding assays remain essential for demonstrating product safety and supporting regulatory submissions. Discover practical strategies for developing sensitive qPCR methods that generate high-quality data for AAV clinical programs.